Is This Medication Safe for My Child? How to Discuss Safety of Commonly Used Medications With Parents.
Allergic rhinitis
Asthma
Atopic Dermatitis
Calcineurin inhibitors
Children
Corticosteroids
Long-acting beta agonists
Montelukast
Safety
Journal
The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
16
05
2022
revised:
25
07
2022
accepted:
30
07
2022
pubmed:
14
8
2022
medline:
15
12
2022
entrez:
13
8
2022
Statut:
ppublish
Résumé
All drugs have potential side effects, but thoughtful use can maximize benefits while minimizing risks. Children should not be considered just small adults regarding drug safety because their growth and development are discordant with their ability to sense and self-report drug side effects. Detecting side effects requires vigilance and education from prescribers to parents, who are tasked with monitoring their child over time. A drug's safety profile is published in the package label after pivotal trials are conducted in relatively small and sometimes narrow segments of the population during the U.S. Food and Drug Administration approval process. Drug safety profiles can change as data from postmarketing reports and long-term monitoring during phase IV trials emerge. As such, prescribers are obligated to maintain current understanding of any changes to drug labels. Discussing potential side effects, monitoring, and when to report concerns can be a time-consuming process during patient encounters. This review offers current information regarding potential side effects of some of the most commonly used medications for allergic conditions, asthma, and atopic dermatitis. This information and discussion will hopefully assist clinicians in their conversations with parents, including advice surrounding prescribing medication to minimize adverse effects, parental monitoring, and documentation.
Identifiants
pubmed: 35963511
pii: S2213-2198(22)00805-4
doi: 10.1016/j.jaip.2022.07.032
pii:
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3064-3072Informations de copyright
Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.